-
Intel Stock Dives As Chipmaker Changes Reporting Structure: Takeaways From 6 Analysts
Wednesday, April 3, 2024 - 12:19pm | 739Intel Corp (NASDAQ: INTC) shares were tanking in early trading on Wednesday, amid news of the company’s foundry business facing a $7 billion loss. BofA Securities On Intel Analyst Vivek Arya reiterated a Neutral rating and price target of $50. At its new reporting structure event, Intel...
-
Marvell Technology's Q4 Had 'More Bad Than Good': 7 Analysts Explore Earnings As Shares Slip
Friday, March 8, 2024 - 3:07pm | 799Shares of Marvell Technology Inc (NASDAQ: MRVL) declined by 9.35% to $77.13 at the time of publication on Friday, after the company reported its fourth-quarter results and issued disappointing guidance. The results came amid an exciting earnings season. Here are some key analyst takeaways from the...
-
CrowdStrike Shares Explode On Q4 Earnings: 12 Analysts Revise Their Forecasts
Wednesday, March 6, 2024 - 1:35pm | 1444CrowdStrike Holdings Inc (NASDAQ: CRWD) shares climbed in early trading on Wednesday, after the company delivered an earnings beat. The results came amid an exciting earnings season. Here are some key analyst takeaways from the release. Piper Sandler On CrowdStrike Analyst Rob Owens reiterated...
-
Should Investors Worry About Zscaler's Deceleration? 12 Analysts Provide Takeaways
Friday, March 1, 2024 - 12:01pm | 1284Shares of Zscaler Inc (NASDAQ: ZS) tanked in premarket trading on Friday, after the company reported higher-than-expected sales and earnings for the fiscal second quarter. The results came amid an exciting earnings season. Here are some key analyst takeaways from the release. Goldman Sachs analyst...
-
Cigna 'Top Pick for 2024': Analysts Change Ratings, Forecasts Following 2024 Guidance
Monday, February 5, 2024 - 1:39pm | 525Cigna Group (NYSE: CI) shares were rising in early trading on Monday after the company reported its fourth-quarter results. The results came amid an exciting earnings season. Here are some key analyst takeaways from the release. Cantor Fitzgerald On Cigna Analyst Sarah James upgraded the rating...
-
Qualcomm Beat Q1 Expectations: Why One Analyst Flags Huawei As A 'Key Risk Factor'
Thursday, February 1, 2024 - 12:47pm | 631Shares of Qualcomm Inc (NASDAQ: QCOM) tanked in early trading on Thursday, even after the company reported strong quarterly results and the extension of its deal with Apple Inc (NASDAQ: AAPL). The results came amid an exciting earnings season. Here are some key analyst takeaways from the release....
-
Bitcoin Halving Could Make 9 Of 11 Largest Public Miners Unprofitable: Analyst
Friday, January 26, 2024 - 1:16pm | 852The Bitcoin (CRYPTO: BTC) Halving in April could make nine of the 11 largest publicly traded Bitcoin miners unprofitable at a Bitcoin price of $40,000, according to a new Cantor Fitzgerald report. What Happened: A preview of the report sees only Bitdeer (NASDAQ: BTDR) and...
-
Texas Instruments Reset 'Not A Shocker,' Analysts Lower Guidance After Q4 Earnings
Wednesday, January 24, 2024 - 12:49pm | 654Shares of Texas Instruments Inc (NASDAQ: TXN) tanked in premarket trading on Thursday, after the company reported its fourth-quarter results. The results came amid an exciting earnings season. Here are some key analyst takeaways from the release. Cantor Fitzgerald analyst C.J. Muse maintained a...
-
ASML Stock: Top Analyst Pick As A 'FIFO' Beneficiary With 21% Upside Ahead Of Q4 Earnings
Tuesday, January 23, 2024 - 7:28pm | 634ASML Holding NV (NASDAQ:ASML) will be reporting its fourth-quarter earnings on Jan. 24. Wall Street expects $5.27 in EPS and $7.53 billion in revenues as the company reports before market hours. ASML is a semiconductor production equipment (SPE) manufacturer. It is known for being a leading...
-
'Data As The New Oil': Semiconductors 'Catching Up' With GDP In 2024, Says Analyst
Tuesday, January 23, 2024 - 5:26pm | 763A Cantor Fitzgerald report on its 2024 Outlook for the semiconductors and semiconductor equipment industry highlighted recent trends in semiconductor revenues. Per analyst C.J. Muse’s analysis, current semiconductor revenue figures are trailing below the GDP trend line. This dip serves as a...
-
Tether 'Has The Money,' Says Billionaire CEO: 'Bitcoin Will Grow'
Tuesday, January 16, 2024 - 6:12pm | 547Cantor Fitzgerald CEO Howard Lutnick believes Tether (CRYPTO: USDT), the biggest stablecoin by market capitalization, has substantial assets and liabilities. What Happened: "There's a company that I like called Tether," he told Bloomberg. "And the group I want to say here...
-
Rivian Cruises With Open Options In EV Space, Not Just Amazon: 6 Analysts Peek Under the Hood Post-Q3
Wednesday, November 8, 2023 - 1:05pm | 751Rivian Automotive Inc (NASDAQ: RIVN) shares tanked in early trading on Wednesday, even after the company reported upbeat third-quarter results. The results came during an exciting earnings season. Here are some key analyst takeaways from the earnings release. Mizuho Securities On Rivian...
-
3 Lucid Group Analysts Unpack Disappointing Q3 Print: 'No New Products' To Boost Margins
Wednesday, November 8, 2023 - 11:43am | 423Shares of Lucid Group Inc (NASDAQ: LCID) tanked in premarket trading on Wednesday, after the company reported disappointing third-quarter (Q3) results. The results came amid an exciting earnings season. Here are some key analyst takeaways from the earnings release. Cantor Fitzgerald analyst Andres...
-
Riot Platforms Analysts Expect Bitcoin Mining Stock To More Than Double
Thursday, September 7, 2023 - 2:50pm | 610Financial services firm Cantor Fitzgerald has highlighted Riot Platforms (NASDAQ: RIOT) as their top pick in the Bitcoin (CRYPTO: BTC) mining sector. The firm's confidence in Riot's potential is evident as it set a price target of $23.00, more than double its current price of $10.98....
-
How To Earn $500 From Pfizer Stock With Shares Trading At 52-Week Low
Wednesday, September 6, 2023 - 6:37pm | 596President Joe Biden’s Inflation Reduction Act, which allows Medicare to negotiate the price of some prescription drugs, remains the talk of the town as investors sell off shares in pharmaceutical companies such as Pfizer Inc. (NYSE: PFE) because drugs associated with the companies...